Home / Cardiovascular system / Labetalol
ATC C07AG01 · Alpha and Beta Blocking Agents
Labetalol shortage
As of 2 Nov 2026, Labetalol has a reported shortage in 2 of the 15 countries we track (Canada, Norway), covering 4 products from 3 companies.
Countries2/15
Products4packs or presentations
Companies31 listed
Short since15 Jul 20224.3 years ago
Earliest return30 Jan 2028company estimate
Main reasonManufacturing problem
United StatesNo reported shortageCanada3 products shortGermanyNo reported shortageFranceNo reported shortageItalyNo reported shortageSpainNo reported shortageIrelandNo reported shortageAustriaNo reported shortageBelgiumNo reported shortageSwitzerlandNo reported shortageCzechiaNo reported shortageNorway1 product shortSwedenNo reported shortageJapanNo reported shortageAustraliaNo reported shortage
Timeline
CanadaNorway
Solid bars run from the reported start to today; faded bars show the time left until the expected return. An arrow means no return date was given.
Which companies are short
products short, all countriesListed: Aspen APN · JSE
Compared with similar medicines
ATC group C07AG · Alpha and Beta Blocking AgentsAffected products
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| CA | TRANDATE (100 tabs) | PALADIN PHARMA INC. | 8 Nov 2024 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | TRANDATE (100 tabs) | PALADIN PHARMA INC. | 8 Nov 2024 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | LABETALOL HYDROCHLORIDE INJECTION USP (1 x 20 mL vial) | JAMP PHARMA CORPORATION | 15 Sep 2026 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| NO | Trandate 5 mg/ml injeksjonsvæske, oppløsning, 5x20 ml ampulle | Aspen Pharma Trading Limited | 15 Jul 2022 | 30 Jan 2028 | Commercial decision or withdrawal Lavt salg |
"Expected back" is the date the company gave the authority, when it gave one. Ask a pharmacist about alternatives.